Advanced Medical Solutions Group Regulatory News (AMS)

3 Jun 2008 12:11



Advanced Medical Solutions Group plc 

("AMS" or "the Company")

Result of Annual General Meeting

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, held its Annual General Meeting this morning at which all resolutions put to shareholders were duly passed. 

Don Evans, AMS's Chief Executive Officer, gave a presentation at the AGM, the slides from which will be made available at the Company's website, www.admedsol.com.

For further information, please contact:

Notes to Editors:

Advanced Medical Solutions is a leading company in the development, manufacture and sale of products into the $15 billion global woundcare market.

Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative products for advanced woundcare and wound closure.

In-house natural and synthetic polymer technology is used to provide advanced wound dressings based on the moist healing principle. AMS' resources ensure a unique position as a vertically integrated 'one stop shop' to provide all categories of moist wound healing products. The Company has the capability to move a product from design and development through to production and delivery ready for distribution into customer markets.

AMS' technology in cyanoacrylate based tissue adhesives is used either for the closure of small cuts and trauma wounds through to large surgical incisions, or for protecting or sealing skin to prevent breakdown or infection. 

AMS' products currently serve the majority of the key global markets sold either direct or through strategic partners or distributors.